Literature DB >> 3159732

Oligosaccharides generated by an endoglucuronidase are intermediates in the intracellular degradation of heparan sulfate proteoglycans.

L Kjellén, H Pertoft, A Oldberg, M Höök.   

Abstract

An intracellular heparan sulfate oligosaccharide has been identified in rat hepatocytes cultured in the presence of [35S]sulfate. Pulse-chase experiments suggest that [35S]sulfate is first incorporated into heparan sulfate proteoglycans which are subsequently converted to the low molecular weight component. The oligosaccharide (Mr 7000) contains little or no protein and is also present in rat liver homogenates. Subcellular fractionation and density gradient centrifugation in Percoll of liver homogenates demonstrated that the oligosaccharide was present in lysosomes or in particles of similar distribution and buoyant density. Structural analysis of oligosaccharides isolated from a rat liver lysosomal fraction indicate that glucuronic acid is present in the reducing end of the oligosaccharide and that this residue is preferentially linked to an N-acetylated glucosamine unit. These data suggest that the heparan sulfate oligosaccharide is generated through the action of a heparan sulfate-degrading endoglucuronidase previously found in human platelets and rat liver (Oldberg, A., Heldin, C.-H., Wasteson, A., Busch, C., and Hook, M. (1980) Biochemistry 19, 5755-5762).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159732

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Evidence that platelet and tumour heparanases are similar enzymes.

Authors:  C Freeman; A M Browne; C R Parish
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 2.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

3.  Oxidative degradation of rat mast-cell heparin proteoglycan.

Authors:  D D Metcalfe; H L Thompson; S J Klebanoff; W R Henderson
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

4.  Human platelet heparanase: purification, characterization and catalytic activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 5.  Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis.

Authors:  E Zcharia; S Metzger; T Chajek-Shaul; Y Friedmann; O Pappo; A Aviv; M Elkin; I Pecker; T Peretz; I Vlodavsky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

6.  Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability.

Authors:  M Moczar; F Caux; M Bailly; O Berthier; J F Doré
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

Review 7.  Proteoglycans and neoplasia.

Authors:  R V Iozzo
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

8.  Heparan sulphate-degrading endoglycosidase in liver plasma membranes.

Authors:  J T Gallagher; A Walker; M Lyon; W H Evans
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

9.  PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction.

Authors:  Elise Miller; Charles Norwood; Jason B Giles; Rachel Huddart; Jason H Karnes; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2022-04-01       Impact factor: 2.089

10.  A rechargeable anti-thrombotic coating for blood-contacting devices.

Authors:  Hyun Ok Ham; Carolyn A Haller; Guowei Su; Erbin Dai; Madhukar S Patel; David R Liu; Jian Liu; Elliot L Chaikof
Journal:  Biomaterials       Date:  2021-07-09       Impact factor: 15.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.